FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Akorn Betaxolol Ophthalmic Solution Recall

Betaxolol Ophthalmic Solution, USP, 0

Akorn, Inc. · Lake Forest, IL

Risk level
Class II
Reported by FDA
Oct 13, 2021
Recall ID
D-0004-2022
Check your lot numberHow we source this data

Summary

Akorn recalled Betaxolol Ophthalmic Solution starting Oct 4, 2021. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0004-2022 on Oct 13, 2021. Reason: Microbial Contamination of Sterile Products: Confirmed sterility failure identified during stability testing at the 12-month time point. Status: Terminated.

Why it was recalled

Microbial Contamination of Sterile Products: Confirmed sterility failure identified during stability testing at the 12-month time point.

Product description

Betaxolol Ophthalmic Solution, USP, 0.5%, (Betaxolol HCl 5.6 mg/mL), 5 mL dropper bottle, Rx only, Sterile, Manufactured by: Akorn, Inc., Lake Forest, IL 60045. Carton NDC: 17478-705-10, Bottle NDC 17478-705-11

Lot numbers, UPCs & expiration codes

Lot 0B61A, Exp 01/31/2022

Where it was sold

Distributed Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0004-2022
Classification
Class II
Status
Terminated
Recall initiated
Oct 4, 2021
FDA report date
Oct 13, 2021
Quantity
10,210 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Akorn, Inc.

Original FDA data

Every field from FDA enforcement report D-0004-2022, exactly as published.

Show all FDA fields
City
Lake Forest
State
IL
Status
Terminated
Country
United States
Event ID
88823
Address
1925 W Field Ct Ste 300
Code information
Lot 0B61A, Exp 01/31/2022
Postal code
60045-4862
Report date
Oct 13, 2021
Product type
Drugs
Recall number
D-0004-2022
Classification
Class II
Recalling firm
Akorn, Inc.
Product quantity
10,210 bottles
Termination date
Aug 17, 2022
Reason for recall
Microbial Contamination of Sterile Products: Confirmed sterility failure identified during stability testing at the 12-month time point.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Betaxolol Ophthalmic Solution, USP, 0.5%, (Betaxolol HCl 5.6 mg/mL), 5 mL dropper bottle, Rx only, Sterile, Manufactured by: Akorn, Inc., Lake Forest, IL 60045. Carton NDC: 17478-705-10, Bottle NDC 17478-705-11
Distribution pattern
Distributed Nationwide in the USA
Recall initiation date
Oct 4, 2021
Initial firm notification
Letter
Center classification date
Oct 7, 2021

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0004-2022, published Oct 13, 2021. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls